Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0370
0.00 (0.00%)
Oct 9, 2025, 8:00 PM EDT
Nu-Med Plus Market Cap
Nu-Med Plus has a market cap or net worth of $3.09 million as of October 10, 2025. Its market cap has decreased by -11.42% in one year.
Market Cap
3.09M
Enterprise Value
3.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since September 25, 2014, Nu-Med Plus's market cap has decreased from 24.57M to 3.09M, a decrease of -87.42%. That is a compound annual growth rate of -17.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 3.09M | 141.04% |
| Dec 31, 2024 | 1.28M | -62.05% |
| Dec 28, 2023 | 3.38M | 151.78% |
| Dec 30, 2022 | 1.34M | -51.67% |
| Dec 31, 2021 | 2.78M | -93.86% |
| Dec 29, 2020 | 45.21M | 141.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |